CClinicalTrials.gg
CompletedNCT00764075EK138/08Updated Jul 7, 2011

Guided Placement of CRT-Leads

An interventional study of Beutel TM and standard in Heart Failure, sponsored by RWTH Aachen University. Completed at 1 site in Germany. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2011-07-07.

Sponsored by RWTH Aachen University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
132
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

In this open, prospective, randomized, parallel group, German-American, two-center, Phase I study the standard-approach CRT-implantation will be compared to a guided CRT-implantation after determining the site of latest contraction and placement of the electrode as close as possible to this site, using a 5-step-scheme of imaging methods determining the site of latest contraction prior to implantation.

Read the detailed description

Patients will be allocated to two groups with either

  1. Guided implantation of the left ventricular lead
  2. Empirical implantation of the left ventricular lead (current clinical standard)

For Treatment Group a) the target vessel, which is the vessel with smallest distance between RLC and CVS is determined in advance and provided to the implanting physician. In case, this vessel is not amenable for lead positioning, a second vessel which is the second closest to the RLC is defined.

For Treatment Group b), the physician has to choose the vessel where to place the electrode without knowing the exact spatial orientation between that particular side-branch and the RLC.

In all patients, standard biventricular devices and leads are to be used. Aspects that are evaluated are:

  1. Technical success in placing the electrode in the target vessel.
  2. Failure due to dislocation during the implantation procedure or phrenic nerve stimulation.

Also, procedure duration, radiation exposure, and complications occurring during the procedure as well as post- operatively will be documented.

02

Conditions studied

  • Heart Failure

Browse trials for

Keywords

  • heart failure; EF<35%; NYHA II, III or IV
03

In context

Heart Failure

5,701 studies on the registry are indexed under Heart Failure; 1,220 are open to participants now.

This study's planned enrollment of 132 is above the median of 72 across 3,736 interventional studies indexed under Heart Failure.

Browse Heart Failure studies →

Lead sponsor

RWTH Aachen University is the lead sponsor of 228 studies on the registry; 19 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Congestive heart failure,
  • Ejection fraction \<35%,
  • Complete left bundle branch block >120ms,
  • NYHA II,III or IV

Exclusion criteria

Exclusion Criteria:

  • Patients not fulfilling the inclusion criteria or not capable/mental able to understand and follow the instructions;
  • Impaired kidney function (GFR \<30ml/min;
  • Pregnant or breastfeeding women
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
132 participants (estimated)

Study arms

  • Experimental
    1

    guided implantation of the left ventricular lead

    Device: Beutel TM

  • Placebo comparator
    2

    standard implantation of the left ventricular lead

    Other: standard

  • Experimental
    Pilot Group

    feasibility of guided placement of CRT-leads in 20 Patients

    Device: software Beutel TM

Interventions

  • DeviceBeutel TM

    application of BeutelTM

  • Otherstandard

    standard procedure will be applied but no Beutel TM software

  • Devicesoftware Beutel TM

    application of BeutelTM to patients data for determination of site of latest contraction

06

What researchers measure

Primary outcomes

  1. Rate of non-responders regarding ejection fraction

    Time frame: 6 months

Secondary outcomes

  1. rate of non-responders regarding NYHA-classification, left end-diastolic and end-systolic volume

    Time frame: 6 months

07

Study locations

1 site
  • Department of Medicine, Division of Cardiology, Pulmonology and Vascular Medicine
    Aachen, NRW 52074, Germany
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 7, 2011, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00764075
Lead sponsor
RWTH Aachen University
Collaborators
University of Chicago
First posted
Oct 1, 2008
Start date
Oct 2008
Primary completion
Apr 2011
Completion
Jun 2011
Last update
Jul 7, 2011

Study contacts

Christian Knackstedt, MD
principal investigator · RWTH Aachen University Departement of Cardiology, Pulmonology and Vascular Medicine

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2011. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion